About University of Colorado; Anschutz Medical Campus Department of Neurology
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Genentech, Inc.
2
Hoffmann-La Roche
2
Intec Pharma Ltd.
2
Cefaly Technology
1
Clinical Trials at University of Colorado; Anschutz Medical Campus Department of Neurology
During the past decade, University of Colorado; Anschutz Medical Campus Department of Neurology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS)
A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis
Long-Term Follow-Up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)
2022-03-29
2029-02-01
Recruiting
500
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at University of Colorado; Anschutz Medical Campus Department of Neurology
According to Clinical.Site data, the most researched conditions in "University of Colorado; Anschutz Medical Campus Department of Neurology" are
"Parkinson's Disease" (2 trials), "Migraine" (1 trials), "Multiple Sclerosis" (1 trials), "Multiple Sclerosis (MS)" (1 trials) and "Multiple Sclerosis, Primary Progressive" (1 trials). Many other conditions were trialed in "University of Colorado; Anschutz Medical Campus Department of Neurology" in a lesser frequency.
Clinical Trials Intervention Types at University of Colorado; Anschutz Medical Campus Department of Neurology
Most popular intervention types in "University of Colorado; Anschutz Medical Campus Department of Neurology" are "Drug" (6 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Accordion Pill™ Carbidopa/Levodopa" (2 trials), "Ocrelizumab" (2 trials), "CEFALY" (1 trials), "Ocrelizumab Dose 1" (1 trials) and "Ocrelizumab Dose 2 and Dose 3" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Colorado; Anschutz Medical Campus Department of Neurology
The vast majority of trials in "University of Colorado; Anschutz Medical Campus Department of Neurology" are
7 trials for "All" genders.
Clinical Trials Status at University of Colorado; Anschutz Medical Campus Department of Neurology
Currently, there are NaN active trials in "University of Colorado; Anschutz Medical Campus Department of Neurology".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in University of Colorado; Anschutz Medical Campus Department of Neurology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of Colorado; Anschutz Medical Campus Department of Neurology, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".